Using the AD TWAS, this approach confirmed the importance of known AD risk genes, such as APOE, BIN1, CD33, CR1, MS4A4A, OAS1 and SPI1 (extracted from the supplementary data of Harwood et al. 16 and summarized in Supplementary Table 8). This evidence concerns the gene APOE and Alzheimer disease.